TY - JOUR
T1 - Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes
AU - University of Washington Center for Mendelian Genomics
AU - Burrage, Lindsay C
AU - Reynolds, John J
AU - Baratang, Nissan Vida
AU - Phillips, Jennifer B
AU - Wegner, Jeremy
AU - McFarquhar, Ashley
AU - Higgs, Martin R
AU - Christiansen, Audrey E
AU - Lanza, Denise G
AU - Seavitt, John R
AU - Jain, Mahim
AU - Li, Xiaohui
AU - Parry, David A
AU - Raman, Vandana
AU - Chitayat, David
AU - Chinn, Ivan K
AU - Bertuch, Alison A
AU - Karaviti, Lefkothea
AU - Schlesinger, Alan E
AU - Earl, Dawn
AU - Bamshad, Michael
AU - Savarirayan, Ravi
AU - Doddapaneni, Harsha
AU - Muzny, Donna
AU - Jhangiani, Shalini N
AU - Eng, Christine M
AU - Gibbs, Richard A
AU - Bi, Weimin
AU - Emrick, Lisa
AU - Rosenfeld, Jill A
AU - Postlethwait, John
AU - Westerfield, Monte
AU - Dickinson, Mary E
AU - Beaudet, Arthur L
AU - Ranza, Emmanuelle
AU - Huber, Celine
AU - Cormier-Daire, Valérie
AU - Shen, Wei
AU - Mao, Rong
AU - Heaney, Jason D
AU - Orange, Jordan S
AU - Bertola, Débora
AU - Yamamoto, Guilherme L
AU - Baratela, Wagner A R
AU - Butler, Merlin G
AU - Ali, Asim
AU - Adeli, Mehdi
AU - Cohn, Daniel H
AU - Jackson, Andrew P
AU - Stewart, Grant S
N1 - Copyright © 2019 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
PY - 2019/3/7
Y1 - 2019/3/7
N2 - SPONASTRIME dysplasia is an autosomal-recessive spondyloepimetaphyseal dysplasia characterized by spine (spondylar) abnormalities, midface hypoplasia with a depressed nasal bridge, metaphyseal striations, and disproportionate short stature. Scoliosis, coxa vara, childhood cataracts, short dental roots, and hypogammaglobulinemia have also been reported in this disorder. Although an autosomal-recessive inheritance pattern has been hypothesized, pathogenic variants in a specific gene have not been discovered in individuals with SPONASTRIME dysplasia. Here, we identified bi-allelic variants in TONSL, which encodes the Tonsoku-like DNA repair protein, in nine subjects (from eight families) with SPONASTRIME dysplasia, and four subjects (from three families) with short stature of varied severity and spondylometaphyseal dysplasia with or without immunologic and hematologic abnormalities, but no definitive metaphyseal striations at diagnosis. The finding of early embryonic lethality in a Tonsl-/- murine model and the discovery of reduced length, spinal abnormalities, reduced numbers of neutrophils, and early lethality in a tonsl-/- zebrafish model both support the hypomorphic nature of the identified TONSL variants. Moreover, functional studies revealed increased amounts of spontaneous replication fork stalling and chromosomal aberrations, as well as fewer camptothecin (CPT)-induced RAD51 foci in subject-derived cell lines. Importantly, these cellular defects were rescued upon re-expression of wild-type (WT) TONSL; this rescue is consistent with the hypothesis that hypomorphic TONSL variants are pathogenic. Overall, our studies in humans, mice, zebrafish, and subject-derived cell lines confirm that pathogenic variants in TONSL impair DNA replication and homologous recombination-dependent repair processes, and they lead to a spectrum of skeletal dysplasia phenotypes with numerous extra-skeletal manifestations.
AB - SPONASTRIME dysplasia is an autosomal-recessive spondyloepimetaphyseal dysplasia characterized by spine (spondylar) abnormalities, midface hypoplasia with a depressed nasal bridge, metaphyseal striations, and disproportionate short stature. Scoliosis, coxa vara, childhood cataracts, short dental roots, and hypogammaglobulinemia have also been reported in this disorder. Although an autosomal-recessive inheritance pattern has been hypothesized, pathogenic variants in a specific gene have not been discovered in individuals with SPONASTRIME dysplasia. Here, we identified bi-allelic variants in TONSL, which encodes the Tonsoku-like DNA repair protein, in nine subjects (from eight families) with SPONASTRIME dysplasia, and four subjects (from three families) with short stature of varied severity and spondylometaphyseal dysplasia with or without immunologic and hematologic abnormalities, but no definitive metaphyseal striations at diagnosis. The finding of early embryonic lethality in a Tonsl-/- murine model and the discovery of reduced length, spinal abnormalities, reduced numbers of neutrophils, and early lethality in a tonsl-/- zebrafish model both support the hypomorphic nature of the identified TONSL variants. Moreover, functional studies revealed increased amounts of spontaneous replication fork stalling and chromosomal aberrations, as well as fewer camptothecin (CPT)-induced RAD51 foci in subject-derived cell lines. Importantly, these cellular defects were rescued upon re-expression of wild-type (WT) TONSL; this rescue is consistent with the hypothesis that hypomorphic TONSL variants are pathogenic. Overall, our studies in humans, mice, zebrafish, and subject-derived cell lines confirm that pathogenic variants in TONSL impair DNA replication and homologous recombination-dependent repair processes, and they lead to a spectrum of skeletal dysplasia phenotypes with numerous extra-skeletal manifestations.
U2 - 10.1016/j.ajhg.2019.01.007
DO - 10.1016/j.ajhg.2019.01.007
M3 - Article
C2 - 30773277
SN - 0002-9297
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
ER -